🇺🇸 FDA
Pipeline program

CANNABIDIOL, DRONABINOL

Phase 2 small_molecule active

Quick answer

CANNABIDIOL, DRONABINOL for Patients with untreatable hepatocellulare carcinoma is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Patients with untreatable hepatocellulare carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials